Browsing Tag
Alpha Cognition
2 posts
Why Alpha Cognition raised $35m now — And what it means for Alzheimer’s drugs
Alpha Cognition (Nasdaq: ACOG) raises $35M in an oversubscribed public offering to drive Alzheimer’s therapy ZUNVEYL—see how investors are reacting.
October 1, 2025
Alpha Cognition advances Alzheimer’s treatment with new patent filing
Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF), a pioneering biopharmaceutical company in the development of novel treatments for…
February 22, 2024